[Diribiotine aerosols administered to patients with chronic bronchial obstruction. Double-blind study].
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000627:therapeutic use; D000596:Amino Acids / Q000008:administration & dosage* / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000008:administration & dosage*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006801:Humans; D007111:Immunity, Cellular; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D009842:Oligopeptides / Q000008:administration & dosage / Q000627:therapeutic use; D011492:Protein Hydrolysates / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D000596:Amino Acids; D001426:Bacterial Proteins; D009842:Oligopeptides; D011492:Protein Hydrolysates; C007531:diribiotine
Aérosols de diribiotine administrés à des malades avec obstruction bronchique chronique. Etude en "double-blind"